● Investor

Novartis Venture Fund

Corporate venture arm of Novartis investing in life sciences and healthcare innovation

Venture CapitalBasel, SwitzerlandSeries B → Series B

Portfolio

2

companies tracked

Rounds · 12mo

1

participated in

Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.

$107M

sum of tracked rounds

Top stage

Series B

by round count

Recent activity

Rounds LatestRounds has tracked from this investor.

EpiBiologicsSan Francisco
Series B$107MJan 8
TruvetaBellevue
Series B$320MOct 5

Where they invest

By stage · rounds, 12mo

Series B1

Frequent co-investors

No repeat co-investors yet.